RBC Capital Maintains Outperform on HCA Healthcare, Lowers Price Target to $435

Benzinga Newsdesk www.benzinga.com Negative 94.4%

Neg 94.4% Neu 0% Pos 0%

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $534 to $435.